Literature DB >> 10595280

Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer.

P Møller1, G Evans, N Haites, H Vasen, M M Reis, E Anderson, J Apold, S Hodgson, D Eccles, H Olsson, D Stoppa-Lyonnet, J Chang-Claude, P J Morrison, G Bevilacqua, K Heimdal, L Maehle, F Lalloo, H Gregory, P Preece, A Borg, N C Nevin, M Caligo, C M Steel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10595280      PMCID: PMC3850824          DOI: 10.1155/1999/920109

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


× No keyword cloud information.
  24 in total

1.  Uptake of BRCA1 genetic testing in adult sisters and daughters of known mutation carriers in Norway.

Authors:  Trine Levin Bodd; Jon Reichelt; Ketil Heimdal; Pal Moller
Journal:  J Genet Couns       Date:  2003-10       Impact factor: 2.537

2.  Risk perception, worry and satisfaction related to genetic counseling for hereditary cancer.

Authors:  Cathrine Bjorvatn; Geir Egil Eide; Berit Rokne Hanestad; Nina Øyen; Odd E Havik; Anniken Carlsson; Gunilla Berglund
Journal:  J Genet Couns       Date:  2007-04       Impact factor: 2.537

Review 3.  Risk assessment and management of high risk familial breast cancer.

Authors:  D G R Evans; F Lalloo
Journal:  J Med Genet       Date:  2002-12       Impact factor: 6.318

4.  Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations.

Authors:  Amy Østertun Geirdal; Jon G Reichelt; Alv A Dahl; Ketil Heimdal; Lovise Maehle; Astrid Stormorken; Pål Møller
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

5.  Impact of familial risk and mammography screening on prognostic indicators of breast disease among women from the Ontario site of the Breast Cancer Family Registry.

Authors:  Meghan J Walker; Lucia Mirea; Kristine Cooper; Mitra Nabavi; Gord Glendon; Irene L Andrulis; Julia A Knight; Frances P O'Malley; Anna M Chiarelli
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

6.  Germline PTEN mutations are rare and highly penetrant.

Authors:  Cecilie F Rustad; Merete Bjørnslett; Ketil R Heimdal; Lovise Mæhle; Jaran Apold; Pål Møller
Journal:  Hered Cancer Clin Pract       Date:  2006-12-15       Impact factor: 2.857

7.  High penetrances of BRCA1 and BRCA2 mutations confirmed in a prospective series.

Authors:  Pål Møller; Lovise Mæhle; Lars F Engebretsen; Trond Ludvigsen; Christoffer Jonsrud; Jaran Apold; Anita Vabø; Neal Clark
Journal:  Hered Cancer Clin Pract       Date:  2010-01-19       Impact factor: 2.857

8.  Towards evidence-based management of inherited breast and breast-ovarian cancer.

Authors:  Pål Møller
Journal:  Hered Cancer Clin Pract       Date:  2004-12-15       Impact factor: 2.857

9.  BRCA1 testing with definitive results: a prospective study of psychological distress in a large clinic-based sample.

Authors:  Jon G Reichelt; Ketil Heimdal; Pål Møller; Alv A Dahl
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

10.  The relationship between psychological distress and personality in women from families with familial breast/ovarian or hereditary non-polyposis colorectal cancer in the absence of demonstrated mutations.

Authors:  Amy Østertun Geirdal; Alv A Dahl
Journal:  J Genet Couns       Date:  2008-07-08       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.